The International College of Psychedelic Medicine
Advancing clinically responsible psychedelic medicine through structured education and professional training.
Why Hollograf Institute Was Established
Psychedelic medicine is entering a critical phase of global development.
Research is accelerating. Regulatory frameworks are evolving. Clinical demand is increasing.
Yet despite this momentum, structured practitioner education remains fragmented and inconsistent internationally.
Hollograf Institute was established to help address that gap.
Clinically grounded education
Professional standards
Practitioner readiness
International collaboration
Our focus is not simply education. It is the long-term development of a globally informed, clinically responsible field.
A New Standard in Clinical Education
The clinical landscape for psychedelic medicine is evolving faster than the education systems designed to support it. Hollograf Institute exists to close that gap — with rigour, independence, and long-term purpose.
Clinical Integrity
Education grounded in evidence, ethics, and professional responsibility
Practitioner Readiness
Preparing clinicians for real-world application, not theoretical frameworks
Regulatory Awareness
Navigating evolving legal and clinical environments with confidence
Real-World Application
Structured for professionals operating in active clinical settings
Clinically Grounded by Design
Hollograf Institute is designed for professionals operating in rapidly evolving clinical environments. Programs are structured around applied knowledge, professional judgement, and responsible implementation — not abstract theory.
Patient Screening Frameworks
Structured approaches to identifying appropriate candidates for psychedelic-assisted care
Treatment Protocols
Evidence-informed frameworks for safe and effective clinical delivery
Ethical & Regulatory Considerations
Navigating the legal, ethical, and professional dimensions of practice
Integration Methodologies
Supporting patients through the therapeutic process and beyond
Case-Based Learning
Real-world clinical scenarios that develop practical decision-making
This is not abstract education. It is designed to support real-world clinical readiness.
Hollograf Institute programs are developed for clinicians and healthcare professionals engaged with emerging treatment environments.
Designed for Professionals
Psychiatrists
Developing advanced clinical understanding of psychedelic-assisted care models and patient selection frameworks.
Medical Practitioners
Engaging responsibly with emerging treatment pathways, referral considerations, and evolving clinical evidence.
Allied Health Professionals
Building structured capabilities in integration support, trauma-informed care, and therapeutic frameworks.
Healthcare Executives & Industry Professionals
Understanding clinical governance, regulatory environments, and the operational realities of emerging healthcare sectors.
Education Pathways
Three structured programs, designed as a progressive learning pathway for healthcare professionals.
Executive Intensive
A focused one-day program providing an authoritative introduction to psychedelic medicine for senior clinicians and healthcare leaders.
1 Day
Clinical Foundations
A structured ten-week program developing applied clinical knowledge across screening, protocols, ethics, and integration.
10 Weeks
Fellowship in Psychedelic Medicine
A comprehensive twelve-month fellowship for clinicians seeking advanced, practice-ready expertise in psychedelic medicine.
12 Months
Full program details, structure, and pricing are available in the prospectus.
Independent by Design
Hollograf Institute operates as a private, independent education provider — outside traditional academic systems. This independence is a deliberate structural choice.
Curriculum updated in line with emerging clinical evidence
Responsive to regulatory developments as they occur
Structured for practical relevance, not institutional convention
Free from the delays inherent in traditional academic governance
In a field evolving as rapidly as psychedelic medicine, the ability to respond with accuracy and speed is not a luxury. It is a clinical responsibility.
Continuing Professional Development
Hollograf Institute programs are designed to align with CPD requirements across relevant healthcare professions, providing structured, clinically relevant learning hours.
Structured Learning Hours
Programs are designed to deliver meaningful, documentable CPD hours across all three pathways.
Clinically Relevant Content
All curriculum is developed with direct reference to professional practice and emerging clinical evidence.
Accreditation Pathways
Formal accreditation pathways are currently under development across relevant professional bodies.
Participants are responsible for confirming CPD recognition within their jurisdiction and professional registration body.
Building a Global Education & Clinical Network
Hollograf Institute is being developed as part of a broader long-term vision for psychedelic medicine — one that extends beyond education into the wider infrastructure of the field.
The broader Hollograf ecosystem encompasses interests across:
Clinical infrastructure
Practitioner training
International collaboration
Emerging research initiatives
This includes participation in cross-border clinical research initiatives through FRAC, alongside long-term exploration of integrated treatment and retreat-based care environments.
The Institute aims to contribute to the development of professional standards, practitioner capability, and responsible implementation frameworks internationally.
Early participants form part of a growing international network helping shape the future of the field.
The Moment Is Now
The conditions for psychedelic medicine's clinical integration are converging. Regulatory environments are shifting. Clinical demand is increasing. Training pathways remain limited.
1/3
Regulatory Shift
Frameworks evolving across multiple jurisdictions
1/3
Clinical Demand
Growing patient and practitioner interest in evidence-based alternatives
1/3
Education Gap
Structured training pathways remain scarce internationally
Education is becoming the gateway to participation in this sector. Those who develop structured clinical knowledge now will help shape how this field develops.
Participate in the Future of Psychedelic Medicine
Hollograf Institute is currently engaging with clinicians, healthcare professionals, educators, and industry participants interested in the responsible development of psychedelic medicine internationally.
If you are a professional seeking structured, credible education in this emerging field — we invite you to learn more.
Hollograf Institute provides education only and does not offer medical advice, diagnosis, or treatment. Completion of any programme does not confer licensure or prescribing rights. Participants are responsible for compliance with all applicable regulations.
© 2026 Hollograf. All rights reserved.
HOLLOGRAF INSTITUTE
Authorised Prescriber Pathway Program
A structured implementation pathway for psychiatrists entering psychedelic-assisted therapy in Australia.
From Interest to Implementation
A structured professional pathway supporting psychiatrists exploring psychedelic-assisted therapies under Australia's TGA Authorised Prescriber framework.
Australia became the first country in the world to establish a regulated pathway allowing authorised psychiatrists to prescribe psilocybin and MDMA under the TGA Authorised Prescriber framework. Yet despite growing clinical interest, very few psychiatrists have successfully navigated the pathway from initial exploration to real-world implementation. The Hollograf Institute Authorised Prescriber Pathway Program was developed to help bridge that gap.
Designed for Clinicians Entering an Emerging Field
This pathway is designed for consultant psychiatrists and clinical leaders who are actively exploring psychedelic-assisted therapies within Australia's regulated framework.
This pathway is designed for:
Consultant psychiatrists
Private psychiatry clinics
Hospital-affiliated clinicians
Research-aligned practitioners
Mental health leaders exploring emerging treatment models
Suitable for psychiatrists interested in:
Treatment-resistant depression
PTSD
Psilocybin-assisted therapy
MDMA-assisted therapy
Clinical governance
Ethical implementation frameworks
Operational readiness
A Structured Clinical Readiness Pathway
Four progressive phases designed to move psychiatrists from initial exploration to first-patient readiness.
01
Exploration & Foundations
Understanding the AP framework, evidence base, ethics, risk, and clinical suitability.
02
Clinical Readiness
Developing protocols, screening systems, consent frameworks, preparation models, and safety procedures.
03
Governance & Ethics
Navigating HREC pathways, SOPs, documentation requirements, clinical defensibility, and risk management.
04
Implementation
Preparing for clinic operations, workflow integration, staffing models, patient pathways, and first-patient readiness.
What the Program Covers
A comprehensive framework spanning clinical education, governance, and operational readiness.
Clinical & Regulatory Education
Structured education across the TGA AP framework, clinical evidence, and regulatory requirements.
Protocol Development Support
Guidance on developing patient screening, consent, preparation, and session protocols.
Ethics & Governance Guidance
Support navigating HREC processes, ethical frameworks, and clinical defensibility.
Operational Readiness
Practical guidance on clinic setup, workflow design, staffing, and patient pathway development.
Peer Cohort Discussions
Structured peer learning with other psychiatrists navigating the same pathway.
Implementation Strategy
Personalised implementation planning to support first-patient readiness.
APAC Program Structure
Three engagement pathways, designed for different levels of clinical readiness and institutional need.
Executive Intensive
Price: From $2,500 AUD
A high-level introduction for psychiatrists evaluating the AP pathway and psychedelic-assisted therapy landscape. Suitable for clinicians at the earliest stage of exploration.
AP Pathway Program
Price: From $7,500 AUD
A structured implementation and readiness pathway combining education, governance guidance, protocol development, and peer support. Designed for psychiatrists committed to clinical implementation.
Institutional Advisory
Price: Custom Engagement
Designed for clinics, hospitals, and mental health organisations exploring structured implementation models at an organisational level.
Full program details, inclusions, and payment options are available in the Program Overview.
A Governance-Focused Approach
The Hollograf Institute is focused on responsible clinical implementation — not on accelerating participation beyond what clinical readiness supports.
Education, Not Approval
Hollograf Institute does not guarantee Authorised Prescriber approval or provide legal advice. Our role is educational and advisory.
Support, Not Substitution
Our programs support — but do not replace — independent clinical judgement. All prescribing decisions remain entirely with the treating clinician.
Guidance, Not Guarantee
We support psychiatrists through education, governance readiness, and implementation planning within an emerging area of medicine.
Hollograf Institute is an education provider. We do not offer medical advice, diagnosis, or treatment.
Helping Shape the Foundations of Psychedelic Medicine
Australia is building the foundations of regulated psychedelic medicine in real time. The psychiatrists entering the field today are not simply early adopters — they are helping establish the standards, governance models, and ethical frameworks that will define this field for decades.
The psychiatrists entering the field today will help shape:
Future treatment standards
Clinical governance models
Ethical frameworks
Patient safety systems
Long-term public trust in the field
This requires more than interest. It requires clinical maturity, governance discipline, and structured implementation support.
HOLLOGRAF INSTITUTE — AUTHORISED PRESCRIBER PATHWAY PROGRAM
Join the Next Generation of Psychiatric Innovation
Applications are currently open for a limited intake of consultant psychiatrists exploring psychedelic-assisted therapies in Australia.
Consultant Psychiatrists Only. Hollograf Institute provides education, governance support, and implementation guidance. All prescribing decisions remain entirely with the treating clinician.